Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-21-000113

Chief Medical Officer acquired 25,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Weiss Lawrence Martin · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-22 Exercise or conversion : show line 1 in the form +6,667 $9.22 $61,470 112,464 D
2021-04-22 Exercise or conversion : show line 2 in the form +9,005 $19.60 $176,498 121,469 D
2021-04-22 Exercise or conversion : show line 3 in the form +9,378 $28.33 $265,679 130,847 D

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-04-22 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,667 $9.22 2023-04-19 6,667 0 D
2021-04-22 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −9,005 $19.60 2024-03-01 9,005 18,012 D
2021-04-22 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −9,378 $28.33 2027-03-02 9,378 28,136 D
Loading xslF345X03/wf-form4_161947371579723.xml…